- Over 16 years of clinical oncology experience, specializing in comprehensive cancer care and advanced therapeutic approaches.
- Awarded "Best Doctor" by the Government of Tamil Nadu consecutively for 2022-2023 and 2023-2024.
- Principal Investigator in multiple Phase II-IV clinical trials involving cutting-edge oncology treatments, including immunotherapies, biosimilars, and targeted therapies.
- Published eight original research articles and two case reports in reputed international and national journals, covering diverse oncology topics from glioblastoma outcomes to compliance with advanced chemotherapy regimens.
- Regular faculty member and speaker at prestigious oncology conferences (e.g., ESMO 2019, Asia Pacific Uro-Oncology Summit 2019), contributing expertise on ovarian cancer, HER2-positive breast cancer, and novel immunotherapies.
- Active contributor to cancer registry programs and hospital-based research to enhance cancer surveillance and patient outcomes.
Dr Arun Ramanan V
Clinical Lead & Senior Consultant - Medical Oncology
Speciality
Cancer Care
Qualification
- MBBS
- MD (RT)
- DM (Medical Oncology)
Experience
16 Years
Gender
Male
Achievements
Qualifications
- MBBS – Thanjavur Medical College (2005)
- MD (Radiotherapy) – Madras Medical College (2010)
- DM (Medical Oncology) – Madras Medical College (2017)
- FIPM – Fellowship in Palliative Medicine
- Certificate in Palliative Care – Indian Association of Palliative Care (2008)
Publications
- "Rare Side Effects of Imatinib – Lichenoid Dermatitis: A Case Report," International Journal of Contemporary Medical Research, 2017.
- "Metronomic Oral Cyclophosphamide Therapy in Recurrent and Advanced Ovarian Cancer Patients: A Retrospective Study," International Journal of Medical Pediatrics and Oncology, 2017.
- "Survival Outcome and Its Predictors for Treated Patients with Glioblastoma Multiforme: A Retrospective Study," IOSR Journal of Dental and Medical Sciences, 2019.
- "Prognostic Factors for Locally Advanced Cervical Cancer Treated by Cisplatin-Based Concurrent Chemoradiotherapy: A Retrospective Study," Asian Journal of Medical Research, 2019.
- "Clinicopathological Features and Outcome of GIST: A Five-Year Data from a Tertiary Cancer Care Centre in South India," European Journal of Molecular & Clinical Medicine, 2022.
- "Compliance of Temozolomide with Concurrent Radiotherapy as an Adjuvant in Patients with High-Grade Glioma: A Retrospective Study," European Journal of Clinical and Experimental Medicine, 2023.
- "ALK-Negative Inflammatory Myofibroblastic Tumor of the Ileum with Liver Metastasis and Paraneoplastic Syndrome: A Diagnostic & Therapeutic Challenge," Journal of International Case Reports (ICARE), 2023.
